Humoral and cellular immune responses to SARS CoV-2 vaccination in Persons with Multiple Sclerosis and NMOSD patients receiving immunomodulatory..
COVIDMS
pirosodust0309 January 5, 2022Software
multiple sclerosis
http://disorders.solutions/multiple-sclerosis/covidms